The risks of pityriasis rosea in pregnancy: a review

Objective:. This review aims to consolidate available evidence, identify research gaps, and advocate for a more informed approach to the management of pityriasis rosea in pregnant individuals. Data Sources:. PubMed, Web of Science, and Directory of Open Access Journals were systematically searched b...

Full description

Saved in:
Bibliographic Details
Main Authors: Sophia Manduca, BS, Christina S. Oh, BA, Michael Ong, BS, Shari R. Lipner, MD, PhD, Miriam K. Pomeranz, MD, Amy K. Bieber, MD
Format: Article
Language:English
Published: Wolters Kluwer 2025-03-01
Series:International Journal of Women's Dermatology
Online Access:http://journals.lww.com/10.1097/JW9.0000000000000191
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849311166738726912
author Sophia Manduca, BS
Christina S. Oh, BA
Michael Ong, BS
Shari R. Lipner, MD, PhD
Miriam K. Pomeranz, MD
Amy K. Bieber, MD
author_facet Sophia Manduca, BS
Christina S. Oh, BA
Michael Ong, BS
Shari R. Lipner, MD, PhD
Miriam K. Pomeranz, MD
Amy K. Bieber, MD
author_sort Sophia Manduca, BS
collection DOAJ
description Objective:. This review aims to consolidate available evidence, identify research gaps, and advocate for a more informed approach to the management of pityriasis rosea in pregnant individuals. Data Sources:. PubMed, Web of Science, and Directory of Open Access Journals were systematically searched based on the keywords “pityriasis rosea,” “pityriasis circinate,” “roseola annulate,” “herpes tonsurans maculosus,” “herald patch,” and “pregnancy” on January 25, 2024 for publications between 1950 to 2024. Study Selection:. Studies containing outcomes data for pregnant patients with established PR were included. Studies must have been written or translated into English and published in a peer-reviewed journal. Studies which did not pertain to PR in the setting of pregnancy were excluded, as screened by two reviewers. Responses, general informational reviews, and letters to the editor without novel data were also excluded. Results:. Eleven relevant articles were identified, encompassing data from 177 patients. Overall, 81% of patients had favorable outcomes while 19% experienced unfavorable outcomes. PR onset before 15 weeks gestation was associated with a higher rate of unfavorable outcomes (41%), including a 27% rate of spontaneous abortion (SA). Conversely, PR onset after 15 weeks had a lower unfavorable outcome rate (21%), and no instances of SA. Conclusion:. Conflicting data exists regarding the impact of PR on pregnancy outcomes. However, PR onset within the first 15 weeks, widespread lesions, constitutional symptoms, and higher human herpesvirus 6 viral loads may increase the risk of unfavorable outcomes such as SA. Close follow-up and consideration of antiviral treatment are recommended for high-risk patients.
format Article
id doaj-art-7487bfc5d45a4bbcb5abce6112325680
institution Kabale University
issn 2352-6475
language English
publishDate 2025-03-01
publisher Wolters Kluwer
record_format Article
series International Journal of Women's Dermatology
spelling doaj-art-7487bfc5d45a4bbcb5abce61123256802025-08-20T03:53:31ZengWolters KluwerInternational Journal of Women's Dermatology2352-64752025-03-01111e19110.1097/JW9.0000000000000191202503000-00005The risks of pityriasis rosea in pregnancy: a reviewSophia Manduca, BS0Christina S. Oh, BA1Michael Ong, BS2Shari R. Lipner, MD, PhD3Miriam K. Pomeranz, MD4Amy K. Bieber, MD5a The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York City, New Yorka The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York City, New Yorkb Department of Dermatology, Weill Cornell Medicine, New York City, New Yorkb Department of Dermatology, Weill Cornell Medicine, New York City, New Yorka The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York City, New Yorka The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York City, New YorkObjective:. This review aims to consolidate available evidence, identify research gaps, and advocate for a more informed approach to the management of pityriasis rosea in pregnant individuals. Data Sources:. PubMed, Web of Science, and Directory of Open Access Journals were systematically searched based on the keywords “pityriasis rosea,” “pityriasis circinate,” “roseola annulate,” “herpes tonsurans maculosus,” “herald patch,” and “pregnancy” on January 25, 2024 for publications between 1950 to 2024. Study Selection:. Studies containing outcomes data for pregnant patients with established PR were included. Studies must have been written or translated into English and published in a peer-reviewed journal. Studies which did not pertain to PR in the setting of pregnancy were excluded, as screened by two reviewers. Responses, general informational reviews, and letters to the editor without novel data were also excluded. Results:. Eleven relevant articles were identified, encompassing data from 177 patients. Overall, 81% of patients had favorable outcomes while 19% experienced unfavorable outcomes. PR onset before 15 weeks gestation was associated with a higher rate of unfavorable outcomes (41%), including a 27% rate of spontaneous abortion (SA). Conversely, PR onset after 15 weeks had a lower unfavorable outcome rate (21%), and no instances of SA. Conclusion:. Conflicting data exists regarding the impact of PR on pregnancy outcomes. However, PR onset within the first 15 weeks, widespread lesions, constitutional symptoms, and higher human herpesvirus 6 viral loads may increase the risk of unfavorable outcomes such as SA. Close follow-up and consideration of antiviral treatment are recommended for high-risk patients.http://journals.lww.com/10.1097/JW9.0000000000000191
spellingShingle Sophia Manduca, BS
Christina S. Oh, BA
Michael Ong, BS
Shari R. Lipner, MD, PhD
Miriam K. Pomeranz, MD
Amy K. Bieber, MD
The risks of pityriasis rosea in pregnancy: a review
International Journal of Women's Dermatology
title The risks of pityriasis rosea in pregnancy: a review
title_full The risks of pityriasis rosea in pregnancy: a review
title_fullStr The risks of pityriasis rosea in pregnancy: a review
title_full_unstemmed The risks of pityriasis rosea in pregnancy: a review
title_short The risks of pityriasis rosea in pregnancy: a review
title_sort risks of pityriasis rosea in pregnancy a review
url http://journals.lww.com/10.1097/JW9.0000000000000191
work_keys_str_mv AT sophiamanducabs therisksofpityriasisroseainpregnancyareview
AT christinasohba therisksofpityriasisroseainpregnancyareview
AT michaelongbs therisksofpityriasisroseainpregnancyareview
AT sharirlipnermdphd therisksofpityriasisroseainpregnancyareview
AT miriamkpomeranzmd therisksofpityriasisroseainpregnancyareview
AT amykbiebermd therisksofpityriasisroseainpregnancyareview
AT sophiamanducabs risksofpityriasisroseainpregnancyareview
AT christinasohba risksofpityriasisroseainpregnancyareview
AT michaelongbs risksofpityriasisroseainpregnancyareview
AT sharirlipnermdphd risksofpityriasisroseainpregnancyareview
AT miriamkpomeranzmd risksofpityriasisroseainpregnancyareview
AT amykbiebermd risksofpityriasisroseainpregnancyareview